Goldman Sachs’s ESSA Pharma EPIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-24,531
| Closed | -$45K | – | 5206 |
|
|
2022
Q3 | $45K | Buy |
24,531
+12,792
| +109% | +$23.5K | ﹤0.01% | 5047 |
|
|
2022
Q2 | $37K | Sell |
11,739
-65,427
| -85% | -$206K | ﹤0.01% | 5337 |
|
|
2022
Q1 | $477K | Sell |
77,166
-17,224
| -18% | -$106K | ﹤0.01% | 4595 |
|
|
2021
Q4 | $1.34M | Sell |
94,390
-27,211
| -22% | -$386K | ﹤0.01% | 3804 |
|
|
2021
Q3 | $973K | Buy |
121,601
+54,827
| +82% | +$439K | ﹤0.01% | 3995 |
|
|
2021
Q2 | $1.91M | Buy |
66,774
+25,783
| +63% | +$737K | ﹤0.01% | 3543 |
|
|
2021
Q1 | $1.19M | Buy |
40,991
+30,707
| +299% | +$892K | ﹤0.01% | 3779 |
|
|
2020
Q4 | $123K | Buy |
+10,284
| New | +$123K | ﹤0.01% | 4433 |
|